Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
REPLICATION

Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators

Udayan Chatterji, Aymeric de Parseval, John H. Elder
Udayan Chatterji
Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aymeric de Parseval
Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John H. Elder
Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jelder@scripps.edu
DOI: 10.1128/JVI.76.19.9624-9634.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    OrfA sequence comparisons. (A) Published sequences of OrfA from different FIV isolates were compared by using the CLUSTALW multiple alignment algorithm. (B) Chou-Fasman and Robson-Garnier consensus secondary structure-forming potential for PPR-OrfA and TM-2 OrfA are compared to show distinctions.

  • FIG. 2.
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    Purification of OrfA. (A) Western blot (lane 1) and Coomassie blue-stained gel (lanes 2 and 3) of purified OrfA showing the presence of both the 9- and the 18-kDa forms (lane 1) and the membrane-purified 9-kDa (lane 2) and its dimeric form (lane 3) analyzed by SDS-10 to 20% PAGE. (B) Dissociation of the OrfA dimer in the presence of 0.5 M β-mercaptoethanol (lane 5) and with simultaneous boiling (lane 6) or neither of these treatments (lane 4), as detected by Western blot analysis with anti-OrfA antibody. Lanes 1 to 3 show identical treatments of the 9-kDa OrfA protein.

    • Open in new tab
    • Download powerpoint
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    Gal4-OrfA assay. (A) PCR strategy followed for generating the Gal4-OrfA deletion clones by PCR-ligation-PCR (see Materials and Methods for details). (B) Diagram of the deletion clones of OrfA fused in frame with the Gal4 DNA-binding domain generated by the strategy describe in panel A. (C) Autoradiogram of the various deletion constructs expressed in vitro under the T7 promoter, immunoprecipitated with anti-OrfA polyclonal serum, and resolved by SDS-10 to 20% PAGE. (D) Transactivation of the G5-E1b-CAT target construct by the different Gal4-OrfA deletion constructs and appropriate controls.

  • FIG. 4.
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Analysis of domains within OrfA. (A) Diagram of the different OrfA deletion constructs used in the present study is shown. (B) Autoradiogram of the various deletion constructs expressed in vitro under the T7 promoter, immunoprecipitated with anti-OrfA polyclonal serum, and resolved by SDS-10 to 20% PAGE.

  • FIG. 5.
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Effect of altering the consensus Kozak sequence in the bicistronic message on the relative expression levels OrfA and Rev. (A) The placement of the Kozak sequence (middle) and its modification (bottom) in the context of the original OrfA sequence (top) is depicted in cartoon form. (B) A total of 1.5 μg each of the Kozak-OrfA-Rev (lanes 1 and 2), Kozak (−1)-OrfA-Rev (lanes 3 and 4), and OrfA-Rev (lanes 5 and 6) constructs were expressed in vitro, and 50% of the lysate were immunoprecipitated with either anti-Rev polyclonal serum (lanes 1, 3, and 5) or anti-OrfA polyclonal serum (lanes 2, 4, and 6). The autoradiogram of the immunoprecipitated products analyzed by SDS-10 to 20% PAGE is presented. The fold levels of the expression with respect to the original sequence are presented on the right of each construct in panel A. (C) Putative hairpin structure at the end of the OrfA reading frame and preceding that of Rev.

  • FIG. 6.
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Generation of OrfA-expressing cell lines. (A) Schematic of the FLAG-tagged OrfA construct coexpressing the neomycin phosphotransferase gene for resistance to G418. (B) The putative OrfA product from nuclear extracts of metabolically labeled C-5-9 cells (lane 2) immunoprecipitated with anti-OrfA antiserum was compared to identically treated CrFK cells (lane 1). (C) CAT assay of the same cell line (C-5-9) used in panel B but transfected with the FIV LTR-CAT construct and assayed for relative CAT levels. As a control, a construct (shown as -LTR) having the CAT gene but lacking the LTR was used to determine background CAT levels for each of these cell lines. In addition, simultaneous cotransfections of CrFK cells with the same FIV-LTRWT-CAT and the FLAG-OrfA constructs were done to serve as a control. The CAT activity from C-4-3, a cell line expressing higher levels of OrfA but exhibiting a high rate of cell death, is also shown.

  • FIG. 7.
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Modulation of LTR activity by OrfA-expressing cell lines. (A) CAT assay of CrFK cells or the C-5-9 cell line transfected with FIV-LTRWT-CAT or FIV-47LTR-CAT constructs and assayed for relative CAT levels. Simultaneous cotransfection of CrFK cells with the same FIV-LTRWT-CAT constructs with or without FLAG-OrfA were performed as a control. (B) CAT activity in the OrfA-expressing cell line C-5-9 transfected with FIV-LTRWT-CAT (WT) or FIV-47LTR-CAT (−47) or having various site-specific deletions (δAP1, δC/EBP, δNF1, and δATF).

  • FIG. 8.
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    Stable expression of OrfA in CrFK and 104-C1 cells. (A) Western blot analysis of equal amounts of lysates from 104-C1 (lanes 1 to 3) or CrFK (lanes 4 to 6) either mock transduced (lanes 1 and 4) or transduced with GFP (lanes 2 and 5) and OrfA-GFP (lanes 3 and 6) with the anti-GFP monoclonal antibody (JL-8; Clontech). (B) Immunoprecipitation with anti-OrfA polyclonal serum (lanes 1 and 2) and anti-GFP antibody (lanes 3 and 4) from equal amounts of cell lysates of 104-C1 cells transduced with either GFP (lanes 1 and 3) or OrfA-GFP (lanes 2 and 4) metabolically labeled with 35S-labeled methionine and cysteine. The arrows point to the positions of OrfA and GFP in the autoradiogram. (C) Micro-RT activity assay of CrFK cells transduced with either GFP or OrfA-GFP infected with 34TF10 or mock infected. The values represent RT activity within the first 5 days postinfection.

PreviousNext
Back to top
Download PDF
Citation Tools
Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators
Udayan Chatterji, Aymeric de Parseval, John H. Elder
Journal of Virology Oct 2002, 76 (19) 9624-9634; DOI: 10.1128/JVI.76.19.9624-9634.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators
Udayan Chatterji, Aymeric de Parseval, John H. Elder
Journal of Virology Oct 2002, 76 (19) 9624-9634; DOI: 10.1128/JVI.76.19.9624-9634.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

capsid
Capsid Proteins
glycoproteins
Immunodeficiency Virus, Feline
Trans-Activators

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514